| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.29 | 8e-08 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 7e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 9e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0004 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |